Skip to main content
. 2022 Oct 13;8(1):53–59. doi: 10.1016/j.ncrna.2022.10.002

Table 1.

Association between miR-153 expression and clinical and pathological characteristics of patients with prostate cancer.

Variables Cases (n) MiR-153 expression
P-value
High (n = 31) Low (n = 30)
Age, years
<55 15 9 6 0.818
≥55 46 24 22
Lymph node metastasis
Yes 29 22 7 0.180
No 32 18 14
Bone metastases
Yes 27 18 9 0.203
No 34 16 18
Gleason score
<8 23 12 11 0.710
≥8 38 23 15
TNM stage
I + II 32 8 24 0.001
IV 29 23 6

TNM, tumor, node, metastasis.